Advertisement

Topics

Aurora Cannabis Inc. Company Profile

13:49 EDT 19th April 2018 | BioPortfolio

Aurora's wholly-owned subsidiary, Aurora Cannabis Enterprises Inc., is a licensed producer of medical cannabis pursuant to Health Canada's Access to Cannabis for Medical Purposes Regulations ("ACMPR"). The Company operates a 55,200 square foot, state-of-the-art production facility in Mountain View County, Alberta, known as "Aurora Mountain", and a second 40,000 square foot high-technology production facility known as “Aurora Vie” in Pointe-Claire, Quebec on Montreal’s West Island. In January 2018, Aurora’s 800,000 square foot flagship cultivation facility, Aurora Sky, located at the Edmonton International Airport, was licensed. Once at full capacity, Aurora Sky is expected to produce over 100,000 kg per annum of cannabis. Aurora is completing a fourth facility in Lachute, Quebec utilizing its wholly owned subsidiary Aurora Larssen Projects Ltd.


News Articles [835 Associated News Articles listed on BioPortfolio]

Is Aurora Cannabis Still a Stock to Buy in 2018?

Aurora Cannabis and its wholly-owned subsidiary, Aurora Cannabis Enterprises Inc., is a licensed producer of medical cannabis pursuant to Health Canada's Access to Cannabis for Medical Purposes Reg...

Aurora Cannabis: So langsam sollte ein Ausbruch folgen!

Lieber Leser, die Aktie von Aurora Cannabis verliert weiter an Boden. Auch wenn die Cannabis Branche sich weitestgehend von der schwachen Phase zu Jahresbeginn erholt hat, kann Aurora Cannabis davo...

Aurora Cannabis: Welches Potential steckt in der Branche?

Lieber Leser, die Aurora Cannabis Aktie profitiert derzeit von der Aussicht auf die Legalisierung von Cannabis in Kanada zu freien Verwendung. Da das Unternehmen bereits Cannabis, im Gegensatz zu a...

Aurora Cannabis Exports Dried Cannabis Flower and Oils to Australia for Novel Nose-to-Brain Drug Delivery Research by PreveCeutical

Edmonton, Alberta and Vancouver, British Columbia--(Newsfile Corp. - March 13, 2018) - Aurora Cannabis Inc. (TSX: ACB) (OTCQB: ACBFF) (FSE: 21P) ("Aurora") and PreveCeutical Medical Inc. (CSE: PREV...

Auf kurzzeitiges Hoch folgt die Ernüchterung - wie sieht die neue Woche bei Aurora Cannabis ...

Die Aurora Cannabis ist eine der Top 3 Produzenten von Cannabis. Den aktuellen Run auf Gewächshäuser und Anbaumöglichkeiten für legales Cannabis scheint das Unternehmen aus Vancouver Kanada aktuel...

Aurora Cannabis: Weichen gestellt

Vor kurzem thematisierten wir an dieser Stelle die spannende charttechnische Konstellation in der Aktie des kanadischen Cannabis-Produzenten Aurora Cannabis und stellten einen Richtungsentscheid in...

Aurora Cannabis & Co.: Blick auf die Bewertung im Vergleich!

Lieber Leser, aufgrund des allgemein negativen Marktumfeldes in der vergangenen Woche verloren alle Aktien großer Cannabis-Produzenten an Wert. Die Aurora Cannabis Aktie schloss dabei mit einem Min.....

Aurora Cannabis: So langsam sollte der Kurswechsel erfolgen!

Lieber Leser, der Kurs der Aurora Cannabis-Aktie hat in den vergangenen Wochen einen erheblichen Verlust erlitten. Das ist mit Blick auf die anderen Cannabis-Unternehmen nicht verwunderlich. Kann s...

PubMed Articles [235 Associated PubMed Articles listed on BioPortfolio]

Does Medical Cannabis Use Increase or Decrease the Use of Opioid Analgesics and Other Prescription Drugs?

: In observational and retrospective studies, people who use cannabis are more likely than people who do not use cannabis to also use other drugs. People who take medical cannabis are also more likely...

Design and synthesis of BPR1K653 derivatives targeting the back pocket of Aurora kinases for selective isoform inhibition.

Twenty five novel chemical analogs of the previously reported Aurora kinase inhibitor BPR1K653 (1-(4-(2-((5-chloro-6-phenylfuro[2,3-d]pyrimidin-4-yl)amino)ethyl)phenyl)-3-(2-((dimethylamino)methyl)phe...

Cannabis dampens the effects of music in brain regions sensitive to reward and emotion.

Despite the current shift towards permissive cannabis policies, few studies have investigated the pleasurable effects users seek. Here we investigate the effects of cannabis on listening to music - a ...

The association between lifetime cannabis use and dysthymia across six birth decades.

Though high rates of co-occurring cannabis use and depression are well-documented, data regarding the association between cannabis use and dysthymia is scarce. The aim of this cross-sectional study wa...

Medicalization of cannabis: What does it mean?

Despite the frequent use of the phrase "medicalization of cannabis," it is not clear what it means to different stakeholders involved in medical cannabis (MC) policy development. This report examines ...

Clinical Trials [157 Associated Clinical Trials listed on BioPortfolio]

Nabilone in Cannabis Users With PTSD

Despite the prevalence of cannabis use among the PTSD population and self-reports that it is used to help cope with PTSD symptoms, the direct effects of cannabis on PTSD symptomology are u...

Effect of Lorcaserin on Cannabis Withdrawal and Self-administration

In this study, the investigators are interested in testing how lorcaserin influences the effects of cannabis in a human laboratory model of cannabis use.

Combined Pharmacotherapy for Cannabis Dependency

The purpose of this study is to see if Lofexidine in combination with Marinol is superior to placebo in achieving abstinence, reducing cannabis use and reducing withdrawal in cannabis-depe...

Combination of Dronabinol and Clonidine for Cannabis Dependence in Patients With Schizophrenia

Cannabis use disorders are an important public health problem in the United States, but no effective pharmacotherapies are available to treat these disorders. People with schizophrenia ar...

A Two-Phase Clinical Study of the Minerva AURORA Ablation System

The primary objective of this study is to evaluate the use of the Aurora Ablation System in reducing menstrual blood loss at 12 months post-treatment. The occurrence of adverse events wil...

Companies [127 Associated Companies listed on BioPortfolio]

Aurora Cannabis Inc.

Aurora's wholly-owned subsidiary, Aurora Cannabis Enterprises Inc., is a licensed producer of medical cannabis pursuant to Health Canada's Access to Cannabis for Medical Purposes ...

Cannabis-Rx, Inc.

Cannabis-Rx (OTCQB:CANA) is focused on funding the licensed cannabis industry by providing cannabis-based businesses with capital and real estate opportunities to enhance operatio...

Cannabis-Rx

Cannabis-Rx (OTCQB: CANA) is focused on funding the licensed cannabis industry by providing cannabis-based businesses with capital and real estate opportunities to enhance operati...

Aurora Biofuels

Aurora Biofuels manufactures fuel from optimized algae in a patented production process. Leading technologists at Aurora Biofuels have engineered a cost-competitive and scalable method for fuel gene...

The Aurora Funds, Inc.

The Aurora Funds is a family of venture capital funds committed to providing resources to help early stage healthcare and information technology companies reach their full potential. Aurora’s invest...

More Information about "Aurora Cannabis Inc." on BioPortfolio

We have published hundreds of Aurora Cannabis Inc. news stories on BioPortfolio along with dozens of Aurora Cannabis Inc. Clinical Trials and PubMed Articles about Aurora Cannabis Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Aurora Cannabis Inc. Companies in our database. You can also find out about relevant Aurora Cannabis Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Antiretroviral therapy
Standard antiretroviral therapy (ART) consists of the combination of at least three antiretroviral (ARV) drugs to maximally suppress the HIV virus and stop the progression of HIV disease. Huge reductions have been seen in rates of death and suffering whe...


Corporate Database Quicklinks



Searches Linking to this Company Record